A Sarah Walker Selected Research

Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)

1/2019	Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.
1/2018	Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
11/2016	Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
3/2016	Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
3/2015	The expanding role of co-trimoxazole in developing countries.
1/2015	Opportunities for improving the efficiency of paediatric HIV treatment programmes.
1/2014	A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
1/2014	Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
4/2011	Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
12/2008	Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Sarah Walker Research Topics

Disease

52	Infections 01/2022 - 03/2003
16	Tuberculosis (Tuberculoses) 01/2022 - 07/2012
11	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 08/2002
10	HIV Infections (HIV Infection) 01/2019 - 03/2003
9	Bacterial Infections (Bacterial Infection) 01/2021 - 08/2006
6	Inflammation (Inflammations) 01/2021 - 01/2012
6	Clostridium Infections 04/2015 - 01/2012
5	Malaria 01/2022 - 01/2014
5	COVID-19 01/2022 - 01/2021
5	Anemia 01/2019 - 04/2011
4	Disease Progression 01/2021 - 09/2004
4	Human Influenza (Influenza) 01/2021 - 01/2018
4	Malnutrition (Nutritional Deficiencies) 01/2019 - 08/2006
3	Sepsis (Septicemia) 01/2022 - 04/2015
3	Reinfection 11/2021 - 05/2014
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 08/2006
3	Body Weight (Weight, Body) 01/2019 - 09/2012
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2016 - 04/2013
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2005
2	Hepatitis C 05/2020 - 10/2018
2	Weight Gain 01/2020 - 01/2018
2	Frailty 01/2020 - 02/2004
2	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 10/2018
2	Communicable Diseases (Infectious Diseases) 12/2019 - 01/2016
2	Cross Infection (Nosocomial Infection) 01/2019 - 04/2017
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2015 - 09/2015
2	Pneumonia (Pneumonitis) 04/2015 - 01/2007
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2015 - 01/2014
2	Pneumococcal Infections 10/2014 - 01/2011
1	Splenomegaly 01/2022
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Fever (Fevers) 01/2021
1	Necrosis 01/2021
1	Flushing 11/2020
1	Cellulitis 10/2020
1	Endocarditis 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Neonatal Sepsis 01/2020

Drug/Important Bio-Agent (IBA)

28	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2007
13	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019 - 01/2007
10	VaccinesIBA 01/2022 - 01/2011
6	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
6	BNT162 VaccineIBA 01/2022 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
6	PENTAIBA 12/2019 - 08/2002
4	Vancomycin FDA LinkGeneric 01/2022 - 08/2012
4	Pharmaceutical PreparationsIBA 01/2019 - 03/2007
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 08/2006
4	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 01/2005
4	Zidovudine (Retrovir)FDA LinkGeneric 02/2016 - 09/2002
4	Nevirapine (Viramune)FDA Link 09/2012 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	AntibodiesIBA 01/2022 - 10/2021
3	Carbapenems (Carbapenem Antibiotics)IBA 01/2021 - 05/2017
3	FidaxomicinIBA 11/2020 - 08/2012
3	Rifampin (Rifampicin)FDA LinkGeneric 10/2018 - 12/2012
3	Methicillin (Metin)FDA Link 10/2018 - 12/2012
3	abacavir (Ziagen)FDA Link 02/2016 - 09/2002
3	RNA (Ribonucleic Acid)IBA 01/2016 - 05/2004
2	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2022 - 05/2014
2	C-Reactive ProteinIBA 01/2021 - 01/2019
2	Lipopolysaccharide ReceptorsIBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
2	FluoroquinolonesIBA 12/2019 - 04/2017
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019 - 04/2017
2	Colistin (Coly-Mycin)FDA Link 01/2019 - 10/2018
2	Raltegravir Potassium FDA Link 01/2018 - 07/2014
2	CreatinineIBA 02/2016 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 10/2015 - 09/2015
2	Conjugate VaccinesIBA 10/2014 - 01/2011
2	Lamivudine (Epivir)FDA Link 06/2006 - 09/2002
1	Palivizumab FDA Link 01/2022
1	hemoglobin AAIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	Tuberculin (PPD)IBA 01/2021
1	InterferonsIBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Neuraminidase (Sialidase)IBA 01/2021
1	Oseltamivir (Tamiflu)FDA Link 01/2021
1	CytokinesIBA 12/2020
1	carbapenemaseIBA 11/2020
1	Antiviral Agents (Antivirals)IBA 05/2020
1	gossypol acetic acidIBA 01/2020
1	BuffersIBA 01/2020
1	methylamphotericin B (AME)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020

Therapy/Procedure

23	Therapeutics 01/2022 - 08/2002
12	Art Therapy 01/2021 - 05/2006
8	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 03/2003
6	Duration of Therapy 12/2020 - 04/2015
4	Antibiotic Prophylaxis 01/2020 - 05/2007
2	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2022
2	Contraindications 10/2018 - 12/2012
1	Conservative Treatment 01/2021
1	Aftercare (After-Treatment) 11/2020